Novitium Pharma

Novitium Pharma is a U.S.-based pharmaceutical company founded in 2016 that specializes in the development, manufacturing, and distribution of niche generic products[6]. The company was acquired by ANI Pharmaceuticals on November 18, 2021, for $210 million[7].

Novitium has developed a growing commercial product portfolio spanning diverse dosage forms and therapeutic categories and has filed over 20 ANDAs (Abbreviated New Drug Applications) with the FDA[5]. The company prides itself on manufacturing its products in the USA at its state-of-the-art facility[1][6].

With approximately 91 employees and an estimated annual revenue of $2 million as of 2025, Novitium continues to invest in producing affordable, high-quality medications to fulfill the needs of pharmacists, patients, and communities[5][6]. The company is headquartered in East Windsor, New Jersey[4][5].